Insider · CIK 0001369900
Noah Berkowitz
Files at IOVA (IOVANCE BIOTHERAPEUTICS, INC.), ARVN (ARVINAS, INC.). First filing Mar 19, 2025, latest May 13, 2026.
In brief
Noah Berkowitz files SEC Form 4 as officer at ARVN (ARVINAS, INC.), and also at IOVA (IOVANCE BIOTHERAPEUTICS, INC.). Since Mar 19, 2025, Noah Berkowitz has reported 0 open-market buys worth $0 and 4 open-market sells worth $324k, the latest filed on May 13, 2026.
A track record needs three past buys with six months of prices behind them; Noah Berkowitz has 0, so none is measured yet.
The newest scored trade: sold $110k of ARVN on May 11, 2026, filed May 13, 2026, scored 40 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $249k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARVN: ARVINAS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | ARVINAS, INC. | $110k 11,108 shares | -5% | +59% from low-30% from high | |
| 23Weak | ARVNsell ARVINAS, INC. | $71k 6,435 shares | -3% | +79% from low-21% from high | |
| 38Weak | ARVINAS, INC. | $68k 5,685 shares | -3% | +92% from low-38% from high | |
| 23Weak | ARVNsell ARVINAS, INC. | $74k 8,658 shares | -7% | +1% from low-70% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 9, 2026 | ARVN ARVINAS, INC. | 37,200 0.06% of outstanding | $329k | Sep 9, 2026 | $544k |
| Sep 4, 2026 | ARVN ARVINAS, INC. | 8,300 0.01% of outstanding | $78k | Sep 4, 2026 | $466k |
| Aug 4, 2026 | ARVN ARVINAS, INC. | 30,000 0.05% of outstanding | $264k | Aug 4, 2026 | $202k |
| Jul 9, 2026 | ARVN ARVINAS, INC. | 24,000 0.04% of outstanding | $202k | Jul 9, 2026 | none |
| May 8, 2026 | ARVN Arvinas Inc | 11,312 0.02% of outstanding | $114k | May 11, 2026 | $139k |
| Mar 17, 2026 | ARVN Arvinas Inc | 6,022 0.01% of outstanding | $72k | Mar 18, 2026 | $68k |
| Feb 13, 2026 | ARVN Arvinas Inc | 5,685 0.01% of outstanding | $68k | Feb 13, 2026 | none |
| Mar 18, 2025 | ARVN Arvinas, Inc. | 8,658 0.01% of outstanding | $74k | Mar 18, 2025 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | AGrant or award Stock Options (Right to Buy)derivative | +135,000 | $0.00 | $0 | 135,000 | 11 d ago |
| Sep 30, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | AGrant or award Restricted Stock Unitsderivative | +180,000 | $0.00 | $0 | 180,000 | 11 d ago |
| Sep 30, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | AGrant or award Performance Stock Unitsderivative | +135,000 | $0.00 | $0 | 135,000 | 11 d ago |
| May 11, 2026 | ARVN ARVINAS, INC. | SOpen-market sale Common Stock | -11,108 | $9.94 | $110k | 191,395 | May 13, 2026 |
| Mar 18, 2026 | ARVN ARVINAS, INC. | SOpen-market sale Common Stock | -6,435 | $11.10 | $71k | 202,503 | Mar 19, 2026 |
| Feb 26, 2026 | ARVN ARVINAS, INC. | AGrant or award Common Stock | +45,000 | $0.00 | $0 | 208,938 | Mar 2, 2026 |
| Feb 26, 2026 | ARVN ARVINAS, INC. | AGrant or award Stock Option (right to buy)derivative | +67,000 | $0.00 | $0 | 67,000 | Mar 2, 2026 |
| Feb 13, 2026 | ARVN ARVINAS, INC. | SOpen-market sale Common Stock | -5,685 | $11.89 | $68k | 163,938 | Feb 18, 2026 |
| May 9, 2025 | ARVN ARVINAS, INC. | AGrant or award Common Stock | +59,600 | $0.00 | $0 | 169,623 | May 13, 2025 |
| May 9, 2025 | ARVN ARVINAS, INC. | AGrant or award Stock Option (right to buy)derivative | +91,000 | $0.00 | $0 | 91,000 | May 13, 2025 |
| Mar 18, 2025 | ARVN ARVINAS, INC. | SOpen-market sale Common Stock | -8,658 | $8.59 | $74k | 110,023 | Mar 19, 2025 |
| Feb 13, 2025 | ARVN ARVINAS, INC. | AGrant or award Common Stock | +55,229 | $0.00 | $0 | 118,681 | Feb 18, 2025 |
| Feb 13, 2025 | ARVN ARVINAS, INC. | AGrant or award Stock Option (right to buy)derivative | +84,330 | $0.00 | $0 | 84,330 | Feb 18, 2025 |
Questions about Noah Berkowitz
Answered from the filings on this page, as of the latest one.
Is Noah Berkowitz buying or selling?
In the last 12 months Noah Berkowitz reported 0 open-market buys worth $0 and 3 open-market sells worth $249k on SEC Form 4; the latest was sold $110k of ARVN on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Noah Berkowitz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Noah Berkowitz has 0.
Where does Noah Berkowitz file Form 4?
Noah Berkowitz has filed Form 4 at ARVN (ARVINAS, INC.) as Chief Medical Officer; IOVA (IOVANCE BIOTHERAPEUTICS, INC.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.